Par Drugs And Chemicals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
PAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Par Drugs and Chemicals has informed the stock exchange that its trading window will remain closed starting Wednesday, October 1, 2025. The closure will stay in effect until 48 hours after the company declares its unaudited financial results for the quarter and half year ended September 30, 2025. The board meeting date to approve these Q2/H1 FY26 results has not yet been disclosed and will be communicated later. During this period, all designated persons, employees, their immediate relatives, and insiders are prohibited from trading in the company's shares. This is a routine compliance measure under SEBI's Insider Trading Regulations, 2015.
No direct impact on shareholders or stock price. This is a standard regulatory disclosure ahead of the upcoming quarterly results, signaling that the company is preparing to announce its Q2 FY26 earnings soon.